Is Prior Authorization Reform on the Horizon?
Government reform and payer streamlining may reduce the burden on healthcare providers, but laboratories should remain vigilant
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Government reform and payer streamlining may reduce the burden on healthcare providers, but laboratories should remain vigilant
Clinical labs gain flexibility in meeting regulatory standards while potentially reducing their costs
The $14.6 billion bust by federal prosecutors shows gaps that every laboratory should monitor
Learn how CLIA could be used as a blueprint to regulate emerging technologies in an effective and dynamic way
Washington State’s Department of Health details how its medical testing site program meets federal standards
The legal strategy of the ACLA—and some political luck—prevailed in the lawsuit against LDT oversight
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing
We explain what ‘tokens’ are, as well as what ‘GPT’ really means
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
UPMC pathology leader discusses steps the lab takes to combat evolving cyber threats
Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior